Survival increased with 131I-burtomab in central nervous system metastases of neuroblastoma June 12, 2017
Eureka Therapeutics and City of Hope enter agreement for phase I clinical testing of ET1402L1 CAR-T June 9, 2017
Burtomab granted breakthrough therapy designation for advanced form of pediatric neuroblastoma June 9, 2017
FDA grants orphan drug status to tavokinogene telsaplasmid in unresectable metastatic melanoma June 9, 2017
RSS